Abeona Therapeutics grants equity awards to new employees under Nasdaq rules.

From “GlobalNewswire”: 2024-09-02 07:30:00

Abeona Therapeutics Inc. granted equity awards to new non-executive employees in accordance with Nasdaq Listing Rule 5635(c)(4). The Compensation Committee approved restricted stock equity awards for four new hires, totaling up to 8,600 restricted shares of Abeona common stock. Vesting of one-third of shares will occur yearly on each anniversary of the Grant Date, with full vesting on the third anniversary, contingent on continued employment. Abeona focuses on developing cell and gene therapies for serious diseases, including the investigational gene therapy, pz-cel, for recessive dystrophic epidermolysis bullosa. The company’s AAV-based gene therapies target ophthalmic diseases with high unmet medical need and utilize novel AAV capsids for improved treatment effectiveness.



Read more at “GlobalNewswire”: Abeona Therapeutics® Announces New Employee Inducement